410
Views
14
CrossRef citations to date
0
Altmetric
Review

Cost analysis of type 2 diabetes mellitus treatment in economically developed countries

ORCID Icon, , &
Pages 5-14 | Received 09 Apr 2018, Accepted 16 Aug 2018, Published online: 04 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luz María Peña-Longobardo, Juan Oliva-Moreno, Neboa Zozaya, Isaac Aranda-Reneo, Marta Trapero-Bertran, Olga Laosa, Alan Sinclair & Leocadio Rodríguez-Mañas. (2021) Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project. Expert Review of Pharmacoeconomics & Outcomes Research 21:1, pages 111-118.
Read now

Articles from other publishers (13)

Keith C. Ferdinand, Keith C. Norris, Helena W. Rodbard & Jennifer M. Trujillo. (2023) Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review. Diabetes Therapy 14:12, pages 1979-1996.
Crossref
Silvia A. G. de Vries, Jessica C. G. Bak, Vincent A. Stangenberger, Michel W. J. M. Wouters, Max Nieuwdorp, Theo C. J. Sas & Carianne L. Verheugt. (2023) Use of hospital care among Dutch diabetes patients. Diabetes, Obesity and Metabolism 25:8, pages 2268-2278.
Crossref
Pennie J. Taylor, Campbell H. Thompson, Thomas P. Wycherley & Grant D. Brinkworth. (2023) A primary care delivered, technology supported lifestyle program for Type 2 Diabetes Management: An evaluation of changes in metabolic health, feasibility, and acceptability – A pilot interventional study protocol. Contemporary Clinical Trials Communications 33, pages 101152.
Crossref
Chioma Uzoigwe, Josh Noone, Yuanjie Liang, Sarah Naz Ali & Cory Gamble. (2022) Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database. Diabetes Therapy 13:11-12, pages 1861-1874.
Crossref
Parasuraman Aiya Subramani, Firdose Begum Shaik, R. Dinakaran Michael, Kalpana Panati & Venkata Ramireddy Narala. (2022) Thiamine: A Natural Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) Activator. Letters in Drug Design & Discovery 19:10, pages 888-896.
Crossref
Yanxian Chen, Zhuoting Zhu, Wei Wang, Xianwen Shang, Mingguang He & Jinying Li. (2022) Association of Myopia With Risk of Incident Metabolic Syndrome: Findings From the UK Biobank Study Cohort of 91,591 Participants. Frontiers in Medicine 9.
Crossref
Wayne H‐H Sheu, Yutaka Seino, Elise Chia‐Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook‐Jin Chung, Koichi Node, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz‐Luyet, Moe H Kyaw & Dae Jung Kim. (2022) Healthcare resource utilization in patients treated with empagliflozin in East Asia. Journal of Diabetes Investigation 13:5, pages 810-821.
Crossref
Rose J. Geurten, Jeroen N. Struijs, Arianne M. J. Elissen, Henk J. G. Bilo, Chantal van Tilburg & Dirk Ruwaard. (2021) Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016–2018. PharmacoEconomics - Open 6:2, pages 219-229.
Crossref
Seyed Sina Ravari, Behrouz Talaei & Zahra Gharib. (2021) The effects of silymarin on type 2 diabetes mellitus: A systematic review and meta-analysis. Obesity Medicine 26, pages 100368.
Crossref
T. Koufakis, O. G. Mustafa, P. Zebekakis & K. Kotsa. (2020) Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close. Diabetic Medicine 37:9, pages 1418-1426.
Crossref
Theocharis Koufakis, George Dimitriadis & Kalliopi Kotsa. (2020) A lion in the room: Has the CAROLINA trial definitely resolved the issue of the cardiovascular safety of sulfonylureas?. Journal of Diabetes 12:7, pages 499-502.
Crossref
Lars Bernfort, Magnus Husberg, Ann-Britt Wiréhn, Ulf Rosenqvist, Staffan Gustavsson, Kristina Karlsdotter & Lars-Åke Levin. (2020) Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study. Diabetes Therapy 11:7, pages 1537-1549.
Crossref
Kostas Athanasakis, Elisavet Prodromiadou, Athanasia Papazafiropoulou, Anastasios Koutsovasilis, Stamatina Driva, Maria Ziori, Elias Georgopoulos, Dimitris Gougourelas, Alexios Sotiropoulos, Stauros Bousboulas, Andreas Melidonis & Stauros Liatis. (2020) Twenty-year trends in the prescription costs of Type 2 diabetes: Real world data and empirical analysis in Greece. Diabetes Research and Clinical Practice 162, pages 108095.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.